Tempest Therapeutics Stock Price on November 25, 2024

TPST Stock  USD 0.79  0.01  1.25%   
If you're considering investing in Tempest Stock, it is important to understand the factors that can impact its price. As of today, the current price of Tempest Therapeutics stands at 0.79, as last reported on the 17th of December 2024, with the highest price reaching 0.83 and the lowest price hitting 0.78 during the day. Tempest Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.17, which indicates the firm had a -0.17% return per unit of risk over the last 3 months. Tempest Therapeutics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Tempest Therapeutics' Risk Adjusted Performance of (0.12), coefficient of variation of (578.65), and Variance of 21.03 to confirm the risk estimate we provide.
  
Tempest Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.1728

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsTPST

Estimated Market Risk

 4.59
  actual daily
40
60% of assets are more volatile

Expected Return

 -0.79
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.17
  actual daily
0
Most of other assets perform better
Based on monthly moving average Tempest Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Tempest Therapeutics by adding Tempest Therapeutics to a well-diversified portfolio.

Related Headline

Indaptus Therapeutics Headline on 25th of November 2024

Filed transaction by Indaptus Therapeutics Director, Officer: Ceo And Director. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Tempest Therapeutics Valuation on November 25, 2024

It is possible to determine the worth of Tempest Therapeutics on a given historical date. On November 25, 2024 Tempest was worth 0.91 at the beginning of the trading date compared to the closed value of 0.92. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Tempest Therapeutics stock. Still, in general, we apply an absolute valuation method to find Tempest Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Tempest Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Tempest Therapeutics' related companies.
 Open High Low Close Volume
  0.89    0.93    0.87    0.91    744,188  
11/25/2024
  0.91    0.98    0.91    0.92    1,135,263  
  0.93    0.98    0.91    0.94    1,189,546  
Backtest Tempest Therapeutics  |  Tempest Therapeutics History  |  Tempest Therapeutics Valuation   PreviousNext  
Open Value
0.91
0.92
Closing Value
14.67
Upside

Tempest Therapeutics Trading Date Momentum on November 25, 2024

On November 26 2024 Tempest Therapeutics was traded for  0.94  at the closing time. The top price for the day was 0.98  and the lowest listed price was  0.91 . The trading volume for the day was 1.2 M. The trading history from November 26, 2024 was a factor to the next trading day price appreciation. The trading price change against the next closing price was 2.17% . The trading price change against the current closing price is 5.43% .

Tempest Therapeutics Fundamentals Correlations and Trends

By evaluating Tempest Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Tempest Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Tempest financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Tempest Therapeutics Stock history

Tempest Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Tempest is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Tempest Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Tempest Therapeutics stock prices may prove useful in developing a viable investing in Tempest Therapeutics
Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecule therapeutics to treat cancer. Tempest Therapeutics Inc. was formerly a subsidiary of Inception Sciences, Inc. Tempest Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 17 people.

Tempest Therapeutics Stock Technical Analysis

Tempest Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Tempest Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Tempest Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Tempest Therapeutics Period Price Range

Low
December 17, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Tempest Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Tempest Therapeutics December 17, 2024 Market Strength

Market strength indicators help investors to evaluate how Tempest Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Tempest Therapeutics shares will generate the highest return on investment. By undertsting and applying Tempest Therapeutics stock market strength indicators, traders can identify Tempest Therapeutics entry and exit signals to maximize returns

Tempest Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Tempest Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Tempest Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Tempest to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Tempest Stock Analysis

When running Tempest Therapeutics' price analysis, check to measure Tempest Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tempest Therapeutics is operating at the current time. Most of Tempest Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tempest Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tempest Therapeutics' price. Additionally, you may evaluate how the addition of Tempest Therapeutics to your portfolios can decrease your overall portfolio volatility.